Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Xenon MRI to Evaluate Changes to Lung Function Following Bronchoscopic Treatment of Air Trapping in Emphysema
NCT07896902Phase 1Recruiting
- Sponsor
- Apreo Health
- Start
- Oct 2026
- Primary completion
- Apr 2028
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial, sponsored by Apreo Health. Primary endpoint: Whole-lung ventilation defect percent at 6 Months. Started Oct 2026; status: recruiting.
Beyond the preview
Go deeper on NCT07896902.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07896902.